Introduction
============

At present, bariatric surgery is the only method available to treat obesity and associated comorbidities with lasting efficacy ([@b1-etm-0-0-7200]). Compared with non-surgical interventions, bariatric surgery achieves a greater improvement with regard to weight loss outcomes and obesity-associated comorbidities, including type 2 diabetes mellitus (T2DM), hypertension and hyperlipemia ([@b2-etm-0-0-7200]). Sleeve gastrectomy (SG) and Roux-en-Y gastric bypass (RYGB) are the two most common procedures used to treat obesity worldwide ([@b3-etm-0-0-7200]). SG is a restrictive and technically less complex procedure than RYGB, which is a procedure that involves a restrictive and malabsorptive mechanism ([@b4-etm-0-0-7200]). The potential mechanisms underlying the excellent outcomes of bariatric surgery include the following: Restriction of dietary intake and nutritional supply ([@b5-etm-0-0-7200]), modulation of gut hormones ([@b6-etm-0-0-7200]) and alterations of inflammatory factors ([@b7-etm-0-0-7200]).

Disorders of gut microbiota are associated with numerous diseases ([@b8-etm-0-0-7200]--[@b10-etm-0-0-7200]). Indeed, studies have demonstrated different patterns of gut microbiota among healthy volunteers, obese patients and T2DM patients ([@b11-etm-0-0-7200],[@b12-etm-0-0-7200]). In recent years, modulation of gut microbiota has been deemed another important mechanism underlying the exceptional outcomes of bariatric surgery ([@b13-etm-0-0-7200]). Tremaroli *et al* ([@b14-etm-0-0-7200]) separately colonized germ-free mice with stool from patients after bariatric surgery and obese controls. They observed a 26--43% elevation of fat deposition of mice colonized with stools from obese controls 9.4 years following bariatric surgery, and they concluded that the changes in the gut microbiota may be one of the factors responsible for the excellent outcomes of bariatric surgery ([@b14-etm-0-0-7200]). Few studies have explored the alterations of the gut microbiota after bariatric surgery, and the populations used in these studies were too small, and the results contained high heterogeneity ([@b14-etm-0-0-7200]--[@b16-etm-0-0-7200]). For this reason, the present study performed a similar analysis of the effect of bariatric surgery on the gut microbiota with the aim of complementing the previously reported data.

Patients and methods
====================

### Patient inclusion and exclusion

A total of 20 healthy volunteers and 26 obese patients with or without T2DM \[19 patients receiving SG and 7 patients receiving RYGB\] were recruited for the present study from August 2017 to May 2018 at Beijing Tiantan Hospital. The healthy volunteers were age and sex matched with the obese patients intending to receive SG. At three months after bariatric surgery, a follow-up examination was performed and the stool was collected from 8 patients receiving SG and 3 patients receiving RYGB. All patients and healthy volunteers provided written informed consent and the present study was approved by the ethics committee of Bejing Tiantan Hospital (Beijing, China). The patient selection criteria for RYGB were as follows: i) Patients were adults, with an age ranging from 18 to 65 years; ii) patients had relatively severe T2DM (duration of T2DM, ≥2 years and T2DM requiring insulin treatment); and iii) the patient\'s desire to receive RYGB. The inclusion criteria for SG were as follows: i) Patients were adults, with the age ranging from 18 to 65 years; ii) patients had relatively minor T2DM (duration of T2DM, \<2 years or T2DM requiring anti-diabetic or dietary therapy); and iii) patients had a body mass index (BMI) of \>28 kg/m^2^. For the healthy volunteers, the inclusion criteria were as follows: i) Volunteers were adults, with the age ranging from 18 to 65 years; ii) a BMI ranging from 18 to 24 kg/m^2^; iii) no T2DM. The following exclusion criteria were applied to all patients and healthy volunteers: i) Antibiotic use within the previous 3 months; ii) pregnancy or the intention of conceiving; iii) previous gastrointestinal surgery; iv) serious mental disease; v) diarrhea within the previous month; vi) use of proton pump inhibitors within the previous month; vii) alcohol use of \>25 g/day; viii) special dietary habits.

Surgical procedures
-------------------

### RYGB

First, the gastric pouch was created with a volume of \~20 ml and the jejunum was then transected 100 cm below the ligament of Treitz. Subsequently, 100 cm of the Roux limb was anastomosed to the gastric pouch (antecolic gastrojejunostomy), and 100 cm of the biliopancreatic limb was subsequently anastomosed in an end-to-side fashion to the distal Roux limb.

SG. A 36Fr orogastric bougie was passed through the anterior wall of the stomach and then cut. The lesser curvature was closed 5--6 cm away from the pylorus towards the cardia with a linear cut stapler.

### Stool sample collection and grouping

In total, 57 stool samples were collected from the 20 healthy volunteers and 26 patients at 3 days pre-operatively, and from 11 patients at 3 months post-operatively. The 57 samples were divided into 5 groups as follows: Control group (CO, n=20), patients prior to SG (SG0, n=19), patients prior to RYGB (RYGB0, n=7), patients after SG (SG3, n=8) and patients after RYGB (RYGB3, n=3). These patients who were lost to follow up following bariatric surgery could not be paired prior to and following surgery, while those patients who were followed up successfully could be. This meant that patients were not strictly paired between SG0 and SG3 or between RYGB0 and RYGB3. The stool samples were self-collected in sterile stool containers and within 2 h, they were stored at −80°C until DNA extraction.

Sequencing
----------

### Extraction of genomic DNA

Total genomic DNA was extracted from the samples using the cetyl trimethylammonium bromide method ([@b17-etm-0-0-7200]). DNA concentration and purity were assessed on 1% agarose gels. According to the concentration in the extract, the DNA was diluted to 1 ng/µl using sterile water.

### Amplicon generation

Distinct regions of 16S ribosomal RNA gene (16S V4) were amplified using a specific primer pair (515 forward, 5′-GTGCCAGCMGCCGCGGTAA-3′; 806 reverse, 5′-GGACTACHVGGGTWTCTAAT-3′; M, H and V represent degenerate bases) with the barcode. All PCRs were performed with Phusion^®^ High-Fidelity PCR Master Mix (New England BioLabs, Inc., Ipswich, MA, USA) according to the manufacturer\'s protocol. The Bio-rad T100 PCR apparatus was utilized (Bio-Rad Laboratories, Inc., Hercules, CA, USA).

### PCR product mixing and purification

The PCR products were mixed with the same volume of 1X loading buffer (Thermo Fisher Scientific, Inc., Waltham, MA, USA; containing SYBR green) and subjected to electrophoresis in a 2% agarose gel for detection. PCR products from various samples were mixed at equal amounts to ensure the evenness of products between samples. Subsequently, the mixtures of PCR products were purified with a GeneJETTM Gel Extraction kit (Thermo Fisher Scientific, Inc.).

### Library preparation and sequencing

Sequencing libraries were generated using an Ion Plus Fragment Library kit 48 rxns (Thermo Fisher Scientific, Inc.) according to the manufacturer\'s protocols. The library quality was assessed using a Qubit^®^ 2.0 Fluorometer (Thermo Fisher Scientific, Inc.). Finally, the library was sequenced on the Ion S5™ XL platform (Thermo Fisher Scientific, Inc.) and 400/600-bp single-end reads were generated.

Data analysis
-------------

### Quality control of single-end reads

Single-end reads were assigned to samples based on their unique barcode and were truncated by removing the barcode and primer sequences. Quality filtering on raw reads was performed under specific filtering conditions to obtain high-quality clean reads according to the Cutadapt quality control process ([@b18-etm-0-0-7200]). The reads were compared with a reference database ([@b19-etm-0-0-7200]) using the UCHIME algorithm ([@b20-etm-0-0-7200]) to detect chimeric sequences, which were then removed ([@b21-etm-0-0-7200]). Ultimately, clean reads were obtained.

### Operational taxonomic units (OTU) cluster and species annotation

Sequence analyses were performed using Uparse software (Version 7.0.1001) ([@b22-etm-0-0-7200]). Sequences with ≥97% similarity were considered to be identical OTUs and deemed to be of one certain species. Representative sequences for each OTU were screened for further annotations. For each representative sequence, the Silva Database ([@b19-etm-0-0-7200]) was used based on the Mothur algorithm to annotate taxonomic information. To explore the phylogenetic association of different OTUs, as well as the differences in the dominant species in different samples (groups), multiple sequence alignments were performed using MUSCLE software version 3.8.31 ([@b23-etm-0-0-7200]). The abundance information of the OTUs was normalized according to a standard sequence number corresponding to the sample with the fewest sequences. Subsequent analyses of α diversity and β diversity were all performed based on this output normalized data.

### α diversity

α diversity is applied when analyzing the complexity of species diversity for a sample through 6 indices, including Observed-species (<http://scikit-bio.org/docs/latest/generated/generated/skbio.diversity.alpha.observed_otus.html?highlight=observed#skbio.diversity.alpha.observed_otus>), Chao1 (<http://www.mothur.org/wiki/Chao>), Shannon (<http://www.mothur.org/wiki/Shannon>), abundance-based coverage estimator (ACE) (<http://www.mothur.org/wiki/Ace>), Good-coverage (<https://en.wikipedia.org/wiki/Coverage_(genetics)>) and phylogenetic diversity (PD)\_whole_tree (<http://scikit-bio.org/docs/latest/generated/generated/skbio.diversity.alpha.faith_pd.html?highlight=pd#skbio.diversity.alpha.faith_pd>). All indices in the present samples were calculated with QIIME (version 1.7.0; <http://qiime.org/>) and displayed with R software (version 2.15.3). The rarefaction curves were generated by using the ggplot2 package for R.

### Characteristics of each of the indices used

Observed-species is a common index reflecting the variety of species in one sample. Chao1 includes the low-abundance species in the formula, so this index is able to better reflect the existence of low-abundance species. Shannon\'s diversity index not only reflects the variety of species but also takes into account the abundance of each species. The ACE index not only reflects the variety of species but also considers the probability that one species exists in one certain sample. The PD_whole_tree index reflects the genetic similarity between species, and further genetic associations between species in a sample indicate a higher PD_whole_tree index. In other words, the evolutionary distance between species in a sample is further and the PD_whole_tree index is higher.

### β diversity

β diversity, on weighted and unweighted unifrac, was calculated with QIIME software (version 1.7.0). The β diversity reflects the compositional difference between samples in one certain group. Weighted unifrac includes abundance and variety of species in the process of calculation, while unweighted unifrac includes only variety. Non-metric multidimensional scaling (NMDS) analysis was performed using the vegan package for R. The linear discriminant analysis effect size (LEfSe) with default parameters was used to identify species with significant differences between groups ([@b24-etm-0-0-7200]). The statistical method applied using LEfSe software (version 1.0 <http://huttenhower.sph.harvard.edu/galaxy/>) was the Kruskal-Wallis test. In order to identify those microbes with beneficial or harmful effects on surgical outcomes, a spearman correlation analysis was performed between species and clinical indexes by using the psych package for R. Spearman correlation analysis was used in all experimental groups (SG0, SG3, RYGB0 and RYGB3). The control group was not included in spearman correlation analysis due to the absence of clinical data, including GHb and Glu. P\<0.05 was considered to indicate statistical significance.

### Data analysis of clinical characteristics

The data analysis of clinical characteristics was performed using SPSS 24.0 software (IBM Corp., Armonk, NY, USA). Continuous data was compared using an unpaired t-test (2 groups) or one-way ANOVA (multiple groups) followed by an LSD post-hoc test. Categorical data was compared using a Fischer\'s exact test.

Results
=======

### Clinical characteristics of the study population

The clinical characteristics of the 5 groups are presented in [Table I](#tI-etm-0-0-7200){ref-type="table"}. The results indicated favorable BMI reduction and T2DM remission of SG and RYGB. The results revealed a markedly lower BMI, T2DM rate and GHb in the SG3 group compared with the SG0 group (P\<0.05). However, due to the small sample size, no statistically significant differences were observed in BMI, T2DM rate, GHb and Glu between the RYGB0 group and the RYGB3 group. In the SG0 group, 14 of the 19 patients included had T2DM. At 3 months following SG, only 8 patients were available for follow-up, 4 of which exhibited pre-operative T2DM, with all of them achieving complete T2DM remission (complete remission rate, 100%). In the RYGB0 group, 7 patients had T2DM. At 3 months following RYGB, only 3 patients were available for follow-up, and of these, 1 achieved complete T2DM remission, while the other 2 patients achieved partial T2DM remission (complete remission rate, 33%). In general, obese patients with a lower BMI, an older age and a more severe T2DM tend to be selected to perform RYGB. As for SG, obese patients with a higher BMI, younger age and relatively less severe T2DM tended to be selected. The relatively lower BMI, older age and more severe T2DM in the RYGB0 group compared with the SG0 group is indicated in [Table I](#tI-etm-0-0-7200){ref-type="table"}. The indexes for determining the severity of T2DM were not the results of glucose and insulin tests, but the duration of T2DM and mode of treatment; in addition, the insulin test is not a routine examination during post-operative follow-up at our institution. For this reason, T2DM was not graded according to glucose and insulin test results. It may be observed from [Table I](#tI-etm-0-0-7200){ref-type="table"} that the female gender ratios in the CO, SG0, RYGB0, SG3 and RYGB3 groups were 70, 74, 57, 100 and 100%, respectively.

### Relative abundance

On the basis of the results of the species annotation, the distribution among the 5 groups at the phylogenetic level was determined. As displayed in the bar graph in [Fig. 1](#f1-etm-0-0-7200){ref-type="fig"}, the top 5 phyla were *Bacteroidetes, Firmicutes, Fusobacteria, Proteobacteria* and *Actinobacteria*. The detailed proportions of the top 10 phyla in the 5 groups are listed in [Table II](#tII-etm-0-0-7200){ref-type="table"}. In the horizontal comparison, a slightly lower proportion of *Bacteroidetes* and a slightly higher proportion of *Fusobacteria* were identified in the CO group compared with those in the SG0 group (P=0.28 for *Bacteroidetes* and P=0.32 for *Fusobacteria*) and the RYGB0 group (P=0.48 for *Bacteroidetes* and P=0.37 for *Fusobacteria*). In the longitudinal comparison, a slightly higher proportion of *Bacteroidetes* was identified in the SG3 group (P=0.49) and the RYGB3 group (P=0.53) compared with that in the SG0 group and the RYGB0 group, respectively.

### α diversity

The α diversity of the 5 groups was calculated in 6 different algorithms, including ACE ([Fig. 2A](#f2-etm-0-0-7200){ref-type="fig"}), Chao1 ([Fig. 2B](#f2-etm-0-0-7200){ref-type="fig"}), Goods_coverage, Observed_species ([Fig. 2C](#f2-etm-0-0-7200){ref-type="fig"}), Shannon ([Fig. 2D](#f2-etm-0-0-7200){ref-type="fig"}) and PD_whole_tree ([Fig. 2E](#f2-etm-0-0-7200){ref-type="fig"}). No statistically significant differences regarding the α diversity were identified among the CO, SG0 and RYGB0 groups. Of note, a significantly higher α diversity was revealed in the SG3 group compared with that in the SG0 group ([Fig. 2](#f2-etm-0-0-7200){ref-type="fig"}). Rarefaction curves were generated according to Chao1 ([Fig. 3A](#f3-etm-0-0-7200){ref-type="fig"}), Observed_species ([Fig. 3B](#f3-etm-0-0-7200){ref-type="fig"}), PD_whole_tree ([Fig. 3C](#f3-etm-0-0-7200){ref-type="fig"}) and Shannon ([Fig. 3D](#f3-etm-0-0-7200){ref-type="fig"}). The rarefaction curves were obtained from multiple samplings of the same individuals and with a variation in the depth of the sequencing; this was used to visually demonstrate the reasonability of the amount of sequencing data. The x-axis of the rarefaction curves represented the amount of sequencing data extracted from one sample and the y-axis represented the number of species. In [Fig. 3](#f3-etm-0-0-7200){ref-type="fig"}, the 5 lines of the 5 groups gradually became flat, which indicated that the amount of sequencing data was appropriate. In other words, if the amount of sequencing data had been further increased, no new species would have been found. The rarefaction curves also reflected the α diversity, and the results were consistent with those in [Fig. 2](#f2-etm-0-0-7200){ref-type="fig"}.

### β diversity

The β diversity of the 5 groups was calculated using the ANOSIM algorithm. Analysis using unweighted_unifrac revealed an obviously higher β diversity in the SG0 group compared with that in the CO group (P\<0.05; [Fig. 4A](#f4-etm-0-0-7200){ref-type="fig"}). Furthermore, analysis with weighted_unifrac indicated a significantly higher β diversity in the SG0 group and the RYGB0 group compared with that in the CO group (P\<0.05), as well as an obviously lower β diversity in the SG3 group compared with that in the SG0 group (P\<0.05; [Fig. 4B](#f4-etm-0-0-7200){ref-type="fig"}). The heterogeneity in the community composition of the 5 groups was presented in a two-dimensional way using an NMDS reduced-dimension graph. The community composition of the SG3 group and the RYGB3 group deviated from that of the CO group, SG0 group and RYGB0 group. The plot of the SG3 group exhibited a converged tendency compared with that of the SG0 group ([Fig. 5](#f5-etm-0-0-7200){ref-type="fig"}).

### Species with statistically significant differences between groups

To identify the species with significant differences between groups at the phylogenetic level, the Kruskal-Wallis test was applied using LEfSe software. The species with statistically significant differences are provided in [Table III](#tIII-etm-0-0-7200){ref-type="table"}. The quantitative data with error bars are available in [Fig. S1A-D](#SD1-etm-0-0-7200){ref-type="supplementary-material"}.

### Spearman correlation test

The Spearman correlation between the abundance of certain microbe and the BMI, as well as GHb and Glu were determined in all experimental groups (SG0, SG3, RYGB0 and RYGB3). The Spearman correlation analysis revealed that there were certain microbes whose abundance were positively or negatively correlated with BMI, GHb and Glu, indicating a counterproductive or beneficial effect, respectively, on surgical outcomes. The microbes with statistically significant differences are provided in [Table IV](#tIV-etm-0-0-7200){ref-type="table"}. The correlation coefficients for each species are included in [Table IV](#tIV-etm-0-0-7200){ref-type="table"}, [Fig. S2](#SD1-etm-0-0-7200){ref-type="supplementary-material"} (phylum), [Fig. S3](#SD1-etm-0-0-7200){ref-type="supplementary-material"} (class), [Fig. S4](#SD1-etm-0-0-7200){ref-type="supplementary-material"} (order), [Fig. S5](#SD1-etm-0-0-7200){ref-type="supplementary-material"} (family), [Fig. S6](#SD1-etm-0-0-7200){ref-type="supplementary-material"} (genus) and [Fig. S7](#SD1-etm-0-0-7200){ref-type="supplementary-material"} (species).

Discussion
==========

The most effective therapy for treating morbid obesity and T2DM is bariatric surgery, and SG and RYGB are the most popular types of bariatric surgery procedures ([@b25-etm-0-0-7200],[@b26-etm-0-0-7200]). In the present study, patients receiving SG or RYGB achieved BMI reduction and T2DM remission; however, the mechanisms responsible for these outcomes in bariatric surgery remain to be fully elucidated. A recently published study suggested that the modulation of gut microbiota may be a possible factor ([@b27-etm-0-0-7200]).

α diversity is an index reflecting the variety of microbial species in stool samples. A higher α diversity indicates more species in one sample ([@b7-etm-0-0-7200]). In the present study, most of the α diversity results were consistent between the different algorithms applied, even though a small variation existed. Due to the different formulas and characteristics of the different algorithms, a small discrepancy was unavoidable ([@b28-etm-0-0-7200]). The present results indicated a similar α diversity between healthy volunteers and obese patients, which was consistent with the results of several cross-sectional studies ([@b29-etm-0-0-7200],[@b30-etm-0-0-7200]). Most previously published studies have observed a higher α diversity in healthy volunteers, but these studies did not provide any underlying causes of the alteration ([@b7-etm-0-0-7200],[@b12-etm-0-0-7200],[@b31-etm-0-0-7200]). The current study did not stratify the T2DM patients into a separate group and as a result, it was impossible to assess the differences between T2DM patients and non-T2DM patients. The differences in gut microbiota between T2DM patients and non-T2DM patients should therefore be investigated in a future stuidies using a larger cohort. The present results indicated an increased α diversity after SG and RYGB, even though no statistical significance was obtained in the RYGB group (P\>0.05). The increase in α diversity after bariatric surgery was also observed by several similar studies ([@b7-etm-0-0-7200],[@b15-etm-0-0-7200],[@b28-etm-0-0-7200],[@b32-etm-0-0-7200],[@b33-etm-0-0-7200]). While the mechanisms underlying the increase in α diversity after bariatric surgery remains elusive, it may be speculated that decreased gastric acid secretion and increased dissolved oxygen in the colon are a potential mechanism.

β diversity is an index reflecting the heterogeneity of gut microbiota between samples in each group. A higher β diversity is indicative of larger compositional differences in the gut microbiota between samples in a certain group ([@b7-etm-0-0-7200]). In the present study, a higher β diversity was observed in obese patients compared with that in healthy volunteers, and after SG, the β diversity decreased towards the level in the heathy volunteers. The results indicated that the heterogeneity of gut microbiota in obese patients is higher than that in heathy volunteers and decreased after bariatric surgery. In line with this, Liu *et al* ([@b7-etm-0-0-7200]) also determined a higher heterogeneity of the gut microbiota in obese patients compared with that in heathy volunteers by using the metagenome method. Only few studies have reported alterations in β diversity after bariatric surgery. Medina *et al* ([@b34-etm-0-0-7200]) reported a decreased β diversity after SG, but Guo *et al* ([@b28-etm-0-0-7200]) reported an unchanged β diversity after SG in animal experiments. The community composition after bariatric surgery tended to deviate from that of patients without bariatric surgery, which indicated that bariatric surgery had a considerable influence on gut microbiota.

Previous studies on species with significant differences between healthy volunteers and obese patients with or without T2DM had a high heterogeneity. In the present study, significant differences in certain species at the phylogenetic level between healthy volunteers and obese patients with or without T2DM were identified. Most of these species belonged to the class of *Clostridia*. Of note, a reduction in *Clostridia* in the gut microbiota has been proven to be associated with obesity ([@b35-etm-0-0-7200],[@b36-etm-0-0-7200]). Certain species of *Clostridia* produce butyrate, the primary energy source of enterocytes ([@b37-etm-0-0-7200]). Furthermore, a reduction in butyrate production increases the permeability of enterocytes, leading to an increase in low-grade inflammation ([@b38-etm-0-0-7200]). The species producing butyrate may also cause satiety, thereby reducing dietary intake ([@b39-etm-0-0-7200]). *Fusobacterium mortiferum* is a species belonging to the *Fusobacteria*. In the present study, the decreased abundance of *Fusobacterium mortiferum* in obese patients was reported for the first time, to the best of our knowledge. Certain previous studies have reported an increased abundance of *Fusobacteria* after bariatric surgery ([@b15-etm-0-0-7200],[@b28-etm-0-0-7200],[@b40-etm-0-0-7200]). In light of this, *Fusobacteria* may potentially be beneficial to obese patients. A decreased amount of *actinobacteria* was observed in obese patients compared with normal subjects in the present study. *Bifidobacteriales* is one of the representative orders among the *actinobacteria*. Several studies have reported a decrease in *Bifidobacteriales* in obese patients and T2DM patients ([@b41-etm-0-0-7200],[@b42-etm-0-0-7200]). *Bifidobacteriales* is also a butyrate producer ([@b43-etm-0-0-7200]) with the function of anti-endotoxaemia ([@b44-etm-0-0-7200]), which has been deemed one of the mechanisms of obesity.

Previous studies focusing on alteration of gut microbiota after bariatric surgery were highly heterogeneous. The present study observed a decrease in *Negativicutes* in the gut microbiota at 3 months after RYGB. Previously published studies have reported an increase in *Negativicutes* caused by a western high-fat diet in mice ([@b45-etm-0-0-7200]). To the best of our konwledge, the present study was the first to report a decrease in *Selenomonadales* after RYGB and an increase in *Rikenellaceae* after SG. A previous study has observed a reduced proportion of *Rikenellaceae* in patients with non-alcoholic fatty liver ([@b46-etm-0-0-7200]), which was, to a certain degree, consistent with the present results. An increase in the *Ruminococcaceae NK4A214* group after bariatric surgery was also reported in the present study, results consistent with this ([@b15-etm-0-0-7200]) and opposite to this ([@b11-etm-0-0-7200]) have been reported, and the discrepancy between the different studies may be associated with differences in the surgical procedures applied. Previous studies reported a decrease in *Faecalibacterium* after RYGB ([@b15-etm-0-0-7200],[@b40-etm-0-0-7200]), which is consistent with the present results, but Furet *et al* ([@b47-etm-0-0-7200]) obtained an opposite result, i.e. a negative correlation between *Faecalibacterium* and low-grade inflammation. *Streptococcus* is part of the normal flora of the oral cavity, which may explain for the increases in *Streptococcaceae, Streptococcus* and *Streptococcus salivarius subspecies thermophilus* after RYGB or SG ([@b48-etm-0-0-7200]). Increases in *Bacilli* and *Lactobacillales* after bariatric surgery were observed in the present study; however, the detailed mechanism remains elusive.

The Spearman correlation between species and BMI, GHb and Glu in the experimental groups (SG0, RYGB0, SG3 and RYGB3) was assessed. The results suggested that the abundance of certain microbes at the phylogenetic level were positively correlated with the BMI, GHb or Glu, and that they appeared to have counterproductive effects on the outcomes of bariatric surgery. By contrast, the species whose abundance was negatively correlated with the BMI, GHb or Glu appeared to have beneficial effects on the outcomes of bariatric surgery. Of note, although no significant alterations of *Akkermansia muciniphila* were identified after bariatric surgery, a positive correlation between *Akkermansia muciniphila* and Glu was determined. Previous studies reported the beneficial effects of *Akkermansia muciniphila* on T2DM and obesity ([@b49-etm-0-0-7200],[@b50-etm-0-0-7200]). The increase in *Akkermansia muciniphila* after bariatric surgery was deemed an important mechanism of the excellent outcomes of bariatric surgery ([@b40-etm-0-0-7200],[@b51-etm-0-0-7200],[@b52-etm-0-0-7200]). The role of *Akkermansia muciniphila* requires to be explored as part of a rigorously designed study with a large sample size. The correlation coefficients ranged from 0.3 to 0.6, which indicated a weak or moderate correlation between the abundance of species and the BMI, as well as GHb and Glu. No species with a high correlation were identified in the Spearman correlation analysis of the present study, and therefore, the present results should be interpreted with caution. Further studies are required to identify the correlation between the abundance of species and the BMI, GHb and Glu.

The following limitations of the study should be considered: i) The small sample size may have impaired the reliability of the results. ii) The healthy volunteers refused invasive testing; hence, it is not known whether any of them may have had undetected T2DM. However, this limitation influenced the results only to a small degree: The most important differential feature between the CO and the experimental group is not T2DM, but the BMI, and the volunteers in the CO group were all of normal weight. iii) The patients were not strictly paired between SG0 and SG3 or between RYGB0 and RYGB3 as certain patients were lost to follow up following bariatric surgery, which amplified the influence of individual microbial differences on the results. iv) The follow-up time was short (3 months after bariatric surgery) and the gut microbiota may have been unstable at that time. v) The inter-group differences in age and sex were important confounding factors that have affected the results of the current study and will need to be assessed in further research.

Bariatric surgery may cause obvious alterations in gut microbiota. Compared with healthy volunteers and obese patients without receiving bariatric surgery, the microbiota composition of post-bariatric surgery patients had unique characteristics. However, studies with a larger cohort and a longer follow-up may be required to confirm these results.
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SG

:   sleeve gastrectomy

RYGB

:   Roux-en-Y gastric bypass
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Glu

:   fast blood glucose
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![α diversity in 5 groups determined by 6 different algorithms. (A) ACE; (B) chao1; (C) observed_species; (D) Shannon; (E) PD_whole_tree. No significant difference was identified in α diversity among the CO group, SG0 group and RYGB0 group. An obviously higher α diversity was obtained in the SG3 group compared with that in the SG0 group (P\<0.05). A tendency of higher α diversity may be distinguished in the RYGB3 group compared with that in the RYGB0 group from A-C. The horizontal lines inside the boxes indicate the median, whereas the lower lines and upper lines of the boxes indicate the 25th and the 75th percentiles, respectively. The upper and lower ends of the vertical lines represent the maximum and minimum points of data, respectively. The dots outside the boxes indicate the outliers (an observation point whose distance from mean value is greater than double standard deviations). CO, control group; SG, sleeve gastrectomy; RYGB, Roux-en-Y gastric bypass; SG0/3, group prior to/3 months after SG; ACE, abundance-based coverage estimator; PD, phylogenetic diversity.](etm-17-03-2268-g01){#f2-etm-0-0-7200}

![Rarefaction curves according to 4 different algorithms. (A) Chao 1. (B) Observed_species. (C) PD_whole_tree. (D) Shannon. The 5 lines of 5 groups gradually became flat, which indicates that the amount of sequencing data was appropriate. In other words, increasing the amount of sequencing would not lead to the discovery of any further species. The rarefaction curve also reflected the increased α diversity in the SG3 and RYGB3 groups compared with that in the SG0 and RYGB0 groups. CO, control group; SG, sleeve gastrectomy; RYGB, Roux-en-Y gastric bypass; SG0/3, group prior to/3 months after SG; PD, phylogenetic diversity.](etm-17-03-2268-g02){#f3-etm-0-0-7200}

![β diversity of 5 groups using the ANOSIM algorithm. (A) Unweighted_unifrac and (B) weighted_unifrac. Analysis with unweighted_unifrac indicated an obviously higher β diversity in the SG0 group compared with that in the CO group (P\<0.05). According to the weighted_unifrac a clearly higher β diversity was present in the SG0 group and the RYGB0 group compared with that in the CO group (P\<0.05), as well as an obviously lower β diversity in the SG3 group compared with that in the SG0 group (P\<0.05). The horizontal lines inside the boxes indicate the median, whereas the lower lines and upper lines of the boxes indicate the 25th and the 75th percentiles, respectively. The upper and lower ends of the vertical lines represent the maximum and minimum points of data, respectively. The dots outside the boxes indicate the outliers (an observation point whose distance from mean value is greater than double standard deviations). CO, control group; SG, sleeve gastrectomy; RYGB, Roux-en-Y gastric bypass; SG0/3, group prior to/3 months after SG; PD, phylogenetic diversity.](etm-17-03-2268-g03){#f4-etm-0-0-7200}

![NMDS reduced-dimension graph. The community composition of the SG3 group and the RYGB3 group deviated from that of the CO group, SG0 group and the RYGB0 group. The plot of the SG3 group exhibited a converged tendency compared to the SG0 group. CO, control group; SG, sleeve gastrectomy; RYGB, Roux-en-Y gastric bypass; SG0/3, group prior to/3 months after SG; PD, phylogenetic diversity; NMDS, non-metric multidimensional scaling.](etm-17-03-2268-g04){#f5-etm-0-0-7200}

###### 

Clinical characteristics of the study population.

  Parameter       CO (n=20)   SG0 (n=19)   RYGB0 (n=7)   SG3 (n=8)   RYGB3 (n=3)   P\<0.05 comparisons
  --------------- ----------- ------------ ------------- ----------- ------------- ------------------------------
  Age (years)     31.5±10.3   32.9±7.1     45.7±9.4      33.3±6.5    40.3±6.8      CO vs. RYGB0; SG0 vs. RYGB0;
  Females         14 (70%)    16 (84%)     4 (57%)       8 (100%)    3 (100%)      
  T2DM                        14 (74%)     7 (100%)      0 (0%)      2 (67%)       SG0 vs. SG3
  BMI (kg/m^2^)   22.4±1.4    41±5.6       30±4.7        30.6±3.8    26.2±2        CO vs. SG0; CO vs. RYGB0;
                                                                                   SG0 vs. SG3
  GHb (%)                     7.4±2        7.8±1.6       5.6±0.4     7.4±1.4       SG0 vs. SG3;
  Glu (mmol/l)                5.7±2.2      7.4±3.4       4.9±0.9     9.3±2.3       

As the healthy volunteers refused invasive testing, T2DM, GHb and Glu for the CO group were not provided. In the SG0 group, 14 out of 19 patients had T2DM. At 3 months after SG, only 8 patients were available for follow-up, 4 of which had pre-operative T2DM, and all of them achieved complete T2DM remission (complete remission rate, 100%). In the RYGB0 group, 7 patients had T2DM. At 3 months after RYGB, only 3 patients were available for follow-up and of these, 1 achieved complete T2DM remission, while the other 2 patients achieved partial T2DM remission (complete remission rate, 33%). T2DM, type 2 diabetes mellitus; BMI, body mass index; GHb, glycosylated haemoglobin; Glu, blood glucose; BMI, body mass index; CO, control group; SG, sleeve gastrectomy; RYGB, Roux-en-Y gastric bypass; SG0/3, group prior to/3 months after SG.

###### 

Detailed proportion of the top 10 phyla in the 5 groups.

  Taxonomy             CO         SG0        RYGB0      SG3        RYGB3
  -------------------- ---------- ---------- ---------- ---------- ----------
  *Bacteroidetes*      0.306591   0.387295   0.372221   0.440632   0.448629
  *Firmicutes*         0.512184   0.441977   0.511654   0.444814   0.467192
  *Fusobacteria*       0.035732   0.000883   0.004699   0.001771   0.019554
  *Proteobacteria*     0.058096   0.093562   0.058359   0.058849   0.046483
  *Actinobacteria*     0.082309   0.064907   0.047962   0.039593   0.010045
  *Cyanobacteria*      0.000983   0.005560   0.000256   0.001785   0.004170
  *Verrucomicrobia*    0.000976   0.003613   0.000915   0.002588   0.003688
  *Spirochaetes*       0.000051   0.000820   0.000107   0.005384   0.000018
  *Tenericutes*        0.002878   0.000035   0.003570   0.000318   0.000089
  *Saccharibacteria*   0.000096   0.000355   0.000084   0.002578   0.000054
  *Others*             0.000103   0.000992   0.000172   0.001688   0.000080

None of the species of phyla exhibited a statistically significant difference in its proportion among the different groups. However, a slightly lower proportion of *Bacteroidetes* and a slightly higher proportion of *Fusobacteria* were identified in the CO group compared with those in the SG0 group (P=0.28 for *Bacteroidetes* and P=0.32 for *Fusobacteria*) and RYGB0 group (P=0.48 for *Bacteroidetes* and P=0.37 for *Fusobacteria*). A slightly higher proportion of *Bacteroidetes* was identified in the SG3 group (P=0.49) and RYGB3 group (P=0.53) compared with the SG0 group and the RYGB0 group, respectively. CO, control group; SG, sleeve gastrectomy; RYGB, Roux-en-Y gastric bypass; SG0/3, group prior to/3 months after SG.

###### 

Taxonomies with statistically significant differences between the groups.

  Comparison        Class                            Order                Family                     Genus                 Species
  ----------------- -------------------------------- -------------------- -------------------------- --------------------- ------------------------------------------------
  CO vs. SG0        *Clostridia↓*                    Clostridiales↓       Ruminococcaceae↓                                 *Fusobacterium_mortiferum↓*
                                                                          *Peptostreptococcaceae↓*                         
  CO vs. RYGB0      *Unidentified_Actinobacteria↓*   Bifidobacteriales↓   Bifidobacteriaceae↓        *Bifidobacterium↓*    
                                                                          *Peptostreptococcaceae↓*   *Megasphaera↓*        
  SG0 vs. SG3       *Bacilli↑*                       Lactobacillales↑     *Streptococcaceae↑*        *Alistipes↑*          *Streptococcus_salivarius_subsp_thermophilus↑*
                                                                          *Rikenellaceae↑*           *Streptococcus↑*      
                                                                          *Porphyromonadaceae↑*                            *Alitipes_finegoldii↑*
  RYGB0 vs. RYGB3   *Bacilli↑*                       *Lactobacillales↑*   *Streptococcaceae↑*        *Streptococcus↑*      *Streptococcus_salivarius_subsp_thermophilus*↑
                    *Negativicutes↓*                 Selenomonadales↓                                *Ruminococcaceae\_*   
                                                                                                     *NK4A214_group↑*      
                                                                                                     *Faecalibacterium*↓   

The LEfSe with default parameters was used to identify species with significant differences between groups. The detailed statistical method used in LEfSe software (version 1.0) was the Kruskal-Wallis test. Increased items are indicated by ↑ and decreased items by ↓. All of the trends indicated in the table had statistical significance (LDA score \>4). CO, control group; SG, sleeve gastrectomy; RYGB, Roux-en-Y gastric bypass; SG0/3, group prior to/3 months after SG; LDA, linear discriminant analysis.

###### 

Spearman correlation between microbes and the BMI, GHb and Glu at different phylogenetic levels.

            BMI                           Glu                             GHb                                                                        
  --------- ----------------------------- ------------------------------- ------------------------- ------------------------------ ----------------- ---------------------------------
  Phylum                                  *Bacteroidetes* (−0.33)                                   *Actinobacteria* (−0.56)                         
  Class     *Negativicutes* (0.43)        *Alphaproteobacteria* (−0.44)                             *Unidentified\_*                                 *Clostridia* (−0.35)
            *Unidentified\_*              *Sphingobacteria* (−0.33)                                 *Actinobacteria* (−0.56)                         
            *Actinobacteria* (0.33)                                                                                                                  
  Order     *Selenomonadales* (0.43)                                                                *Bifidobacteriales* (−0.56)                      *Clostridiales* (−0.36)
            *Bifidobacteriales* (0.47)                                                                                                               
  Family    *Vellonellaceae* (0.42)       *Rikenellaceae* (−0.4)                                    *Bifidobacteriaceae* (−0.56)                     *Rikenellaceae* (−0.48)
            *Bifidobacteriaceae* (0.47)   *Streptococcaceae* (−0.43)                                *Alcaligenaceae* (−0.34)                         *Ruminococcaceae* (−0.33)
                                          *Porphyromonadaceae* (−0.42)                              *Acidaminococcaceae* (−0.33)                     *Lachnospiraceae*(−0.33)
                                          *Phyllobacteriaceae* (−0.36)                                                                               *Porphyromonadaceae* (−0.37)
                                                                                                                                                     *Peptostreptococcaceae* (−0.35)
  Genus     *Megasphaera* (0.35)          *Alistipes* (−0.33)             *X.Eubacterium.\_*        *Megasphaera* (−0.42)                            *Alistipes* (−0.44)
            *Bifidobacterium* (0.47)      *Streptococcus* (−0.43)         *ruminantium_group*       *Bifidobacterium* (−0.57)                        *Parabacteroides* (−0.34)
                                          *Parabacteroides* (−0.4)        (0.44)                                                                     *Blautia* (−0.3)
                                          *Phyllobacterium* (−0.36)       *Prevotella \_9* (0.39)                                                    
                                          *Coprococcus_2* (−0.35)         *Akkermansia* (0.33)                                                       
                                          *A214_group* (−0.5)                                                                                        
                                          *Ruminococcaceae.\_*                                                                                       
                                          *NK4* (−0.5)                                                                                               
                                          *Ruminococcaceae\_*                                                                                        
                                          *UCG.002* (−0.37)                                                                                          
                                          *X.Eubacterium.\_*                                                                                         
                                          *ruminantium_group*                                                                                        
                                          (−0.46)                                                                                                    
  Species   *Megasphaera_elsdenii*        *Streptococcus_salivarius\_*    *Akkermansia\_*           *Megasphaera\_*                Lactobacillus\_   *Bacteroides_plebeius* (−0.35)
            (0.33)                        *subsp_thermophilus* (−0.42)    *muciniphila* (0.34)      *elsdenii* (−0.37)             mucosae (0.33)    *Bacteroide\_ dorei* (−0.36)
                                          *Parabacteroides_merdae*        *Bacterium_OL.1*          *Bacteroides\_*                                  *Ruminococcus_sp_5\_1\_*
                                          (−0.35)                         (−0.37)                   *coprocola* (−0.43)                              *39BFAA* (−0.38)
                                          *Bacteroides_caccae* (−0.35)                                                                               *39BFAA* (−0.38)
                                                                                                                                                     *Blautia_obeum* (−0.33)
                                                                                                                                                     *Bacteroides_nordii* (−0.36)

All of the species listed in the table exhibited a statistically significant difference in correlation between microbes and the BMI, GHb and Glu (P\<0.05). The numbers in parentheses are the correlation coefficients. BMI, body mass index; GHb, glycosylated hemoglobin; Glu, blood glucose; Positive, positive correlation; Negative, negative correlation.
